In focus · trending topic

Bempedoic Acid/Ezetimibe Combo

9 stories · following the connections

Esperion Announces Positive Top-Line Results From Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin

By Nasdaq OMXAug 8, 2017, 11:30 AM UTC